| > Dr Jun-Li Liu
Dr. Liu's research has provided solid evidence that liver- and pancreas-derived
IGF-I, as well as GH signals play important roles in the growth
of pancreatic islets, maintaining normal level of insulin production,
controlling sensitivity to insulin, and maintaining ß-cell integrity
in response to experimental damage.
Dr. Liu has a research team consists of 1 postdoctoral fellow, 2
PhD students, 1 research assistant, and several undergraduate students.
His lab is part of the Fraser Laboratories for Diabetes Research
at the Royal Victoria Hospital of the McGill University Hospital
Dr. Jun-Li Liu
Dr. Jun-Li Liu studied Biology/Physiology at Peking
University, China, where he obtained his BSc (1982) and MSc (1985)
degrees. He came to Canada in 1989 for postgraduate study and research
training in molecular endocrinology under the late Dr. Yogesh C
Patel and received his PhD degree in Experimental Medicine at McGill
University in 1995. Dr. Liu subsequently worked for five years as
a postdoctoral fellow with Dr. Derek LeRoith (Diabetes Branch, NIDDK,
NIH, Bethesda, MD). There he initiated work on Cre/loxP-mediated
conditional targeting of the mouse IGF-I gene and studied the effect
of liver-specific IGF-I gene deficiency in growth and metabolism.
In 2000 he was recruited by McGill University as Assistant Professor
of Medicine. The focus of his current research is the role of growth
hormone and insulin-like growth factors in pancreatic islet growth
and insulin production using various knockout and transgenic mice.
Liu received a Career Development award from the JDRF and a Fellowship
Award from the Medical Research Council of Canada. His has also
received research awards from the Endocrine Society and the NIH
(intramural division). Dr. Liu has published over 30 peer-reviewed
and review articles and has been invited to present his work at